SYM Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
SYM Financial's XBI Position: Q3 2026 in Review
SYM Financial sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2026, closing a stake of 18 shares — an estimated $2.85K sold.
SYM Financial first reported a position in XBI in Q4 2018 and held it in 5 quarters. The position peaked at $30K in Q1 2019. 820 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- SYM Financial reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2026 after selling out during the quarter.
- SYM Financial sold 18 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $2.85K.
- SYM Financial first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and held it in 5 quarters.
- SYM Financial's State Street SPDR S&P Biotech ETF position peaked at $30K in Q1 2019.
- 820 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on SYM Financial's 13F filing for Q3 2026, filed 26 Oct 2026.